Antitrust
FPO: Federal Court Dismisses Derivative Complaint Seeking to Impose ESG Initiatives on a Public Company
By Jessamy Gallagher on September 30, 2018
In the past year, there has been a concerted effort by certain plaintiff firms to weaponize environmental, social, and governance (“ESG”) principles to attack corporate boards. On March 19, 2021, the United States District Court for the Northern District of California in Ocegueda v. Zuckerberg, Ca. No. 3:20-cv-04444-LB (N.D. Cal. Mar. 19, 2021), struck a blow against these efforts by granting defendants’ motion to dismiss.
FPO: Jasper Therapeutics to Merge with Amplitude Healthcare Acquisition Corporation to Create a Publicly Listed Leading Biotechnology Company in Hematopoietic Stem Cell Transplantation
By Jason M. Rednour on September 26, 2018
FPO: Palo Alto – Paul Hastings LLP, a leading global law firm, announced today that the firm served as legal advisor to Jasper Therapeutics, Inc. (Jasper Therapeutics) in its agreement to merge with A...